Hurtado-Arias JJ, Peralta-Amaro AL, García-Ramírez C

Language: Spanish
References: 10
Page: 17-22
PDF size: 241.89 Kb.

ABSTRACT

Objective: To describe the prevalence of tertiary hyperparathyroidism a year after successful kidney graft in a tertiary care center. Material and methods: Retrospective observational study to assess tertiary hyperparathyroidism after a year of transplantation in patients who meet the selection criteria and have a complete clinical record, over a period of five years. Taking into account the duration of dialysis, calcium, phosphorus, parathyroid hormone before and after renal graft. The statistical analysis was carried out with the statistical software SPSS 20.0. Results: 512 patients with renal transplant were identified during this period; 284 were eliminated and from the lasting 228 67.1% (153 patients) presented tertiary hyperparathyroidism. Conclusions: Tertiary hyperparathyroidism was demonstrated with a higher prevalence than described in other international studies, with associated independent risk factors; dialysis duration greater than 72 months, PTH > 300 pre-transplantation, and Ca/P ratio > 55 (p < 0.001).

REFERENCES

1. Torregrosa JV, Bover J, Cannata-Andía J, Lorenzo V, de Francisco AM, Martínez I et al. Recomendaciones de la Sociedad Española de Nefrología para el manejo de las alteraciones del metabolismo óseo-mineral en los pacientes con enfermedad renal crónica (S.E.N.-MM). Nefrología. 2011; 31 (1): 3-32.

2. Fraser WD. Hyperparathyroidism. Lancet. 2009; 374: 145-158.

3. Fukagawa M, Kazama JJ, Kurokawa K. Renal osteodystrophy and secondary hyperparathyroidism. Nephrol Dial Transplant. 2002; 17 (10): 2-5.

4. Yuen NK, Ananthakrishnan S, Campbell MJ. Hyperparathyroidism of renal disease. Perm J. 2016; 20 (3): 15-127.

5. López A, García F, Sierra M, Galindo J. Tratado de geriatría para residentes. Sociedad española de geriatría y gerontología 2006; Capítulo 60 Interpretación de las pruebas del metabolismo calcio-fósforo: 615-626.

6. Dávila-Fajardo CL, Barrera JC, Prados-Garrido MD, García AS. Efectividad y eficiencia de paricalcitol en el tratamiento del hiperparatiroidismo secundario a insuficiencia renal. Dial Traspl. 2009; 30 (4): 122-126.

7. Lou I, Foley D, Odorico SK, Leverson G, Schneider DF, Sippel R et al. How well does renal transplantation cure hyperparathyroidism? Ann Surg. 2015; 262: 653-659.

8. Yamamoto T, Tominaga Y, Okada M, Hiramitsu T, Tsujita M, Goto N et al. Characteristics of persistent hyperparathyroidism after renal transplantation. World J Surg. 2015; 268 (15): 17-43.

9. Nakai K, Fujii H, Ishimura T, Fujisawa M, Nishi S. Incidence and risk factors of persistent hyperparathyroidism after kidney transplantation. Transplantation Proceedings. 2017; 49: 53-56.

10. Lou I, Schneider DF, Leverson G, Foley D, Sippel R, Chen H. Parathyroidectomy is underutilized in patients with tertiary hyperparathyroidism after renal transplantation. Surgery. 2016; 159 (1): 172-180.